02 April 2020
In these uncertain times as we cope with the COVID-19 pandemic, the Global Psoriasis Atlas (GPA) has sparked hope with its latest successes. First, we are pleased to announce that the GPA will launch the next phase of its work plan. Phase II (2020-2023) follows a series of successful milestones from Phase I. At the recent Board of Governors Annual Meeting held by teleconference in April 2020, GPA Director, Prof. Chris Griffiths noted that this has been a year of success for the Global Psoriasis Atlas and the psoriasis community has lots to celebrate. This meeting was attended by IFPA’s president, Dr. Hoseah Waweru, and collaborating partners the International League of Dermatological Societies (ILDS) and the International Psoriasis Council (IPC).
Second, while research has stopped in most parts of the world, the Atlas has pressed forward with their collaborating partners IFPA, ILDS and IPC. We will continue to engage academic and scientific and institutions via video conferencing. Now, when people with psoriasis need data more than ever, is not the time to abandon our work. In the Steering committee meeting the GPA Phase I efforts have been applauded and publications have been picked up by major media news outlets around the world, including a recent study on the increased risk of cancer among people living with psoriasis.
The Atlas has achieved all its set milestones for 2017-2020. Already in its first three years the Atlas has established itself as a recognizable and respected brand around the world. The next three-year phase will build on the existing foundation and address knowledge gaps on the burden of disease, including the co-morbid burden and economic impact.
Learn more at globalpsoriasisatlas.org